Trial Profile
A new induction therapy (ThalDoDex) for multiple myeloma. A phase II study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2011
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Doxorubicin liposomal (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 Jun 2011 New trial record